Aims In subcutaneous implantable cardioverter defibrillator (S-ICD) recipients, the
UNTOUCHED study demonstrated a very low inappropriate shock rate on programming a …

Aims Assess subcutaneous implantable cardioverter-defibrillator (S-ICD) effectiveness in the
prevention of sudden cardiac death and the impact of demographics and the initial detection …

Background The subcutaneous implantable cardioverter-defibrillator system (S-ICD) uses a
novel detection algorithm previously shown to discriminate induced tachyarrhythmias …

Background Most inappropriate shocks from the subcutaneous implantable cardioverter-
defibrillator (S-ICD) are caused by cardiac oversensing. A novel sensing methodology …

The subcutaneous implantable cardioverterdefibrillator (S-ICD) was developed in response
to endovascular lead complications with traditional transvenous implantable cardioverter …

Aims Patients with cardiomyopathies and channelopathies are usually younger and have a
predominantly arrhythmia-related prognosis; they have nearly normal life expectancy thanks …

Background The subcutaneous implantable cardioverter defibrillator (S‐ICD) has been
established as a valuable alternative to transvenous ICD for prevention of sudden cardiac …

Background The incidence, risk factors, and management of very high defibrillation
thresholds (DFTs) during present-day implantable cardioverter defibrillator (ICD) testing are …

Background The entirely subcutaneous implantable cardioverter-defibrillator (S-ICD)
eliminates the need for transvenous leads, and therefore has the potential to improve lead …

Background Since the introduction of the subcutaneous implantable‐defibrillator (S‐ICD)
knowledge of factors elevating the defibrillation threshold (DFT), have increased. Optimal …